arginine methyl ester has been researched along with Chronic Kidney Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alarcon Arias, SC; Albino, AH; Ávila, VF; Camara, NOS; Faustino, VD; Fujihara, CK; Malheiros, DMAC; Oliveira, KC; Zambom, FFF; Zatz, R | 1 |
1 other study(ies) available for arginine methyl ester and Chronic Kidney Diseases
Article | Year |
---|---|
NF-κB blockade during short-term l-NAME and salt overload strongly attenuates the late development of chronic kidney disease.
Topics: Animals; Arginine; Enzyme Inhibitors; Kidney; Kidney Glomerulus; Nephritis; NF-kappa B; NG-Nitroarginine Methyl Ester; Rats, Wistar; Renal Insufficiency, Chronic; Sodium Chloride; Sodium Chloride, Dietary | 2020 |